Singapore markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.3500-0.0936 (-21.10%)
At close: 04:00PM EDT
0.3501 +0.00 (+0.03%)
After hours: 07:57PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.27-0.24-1.28-0.81
Low estimate-0.35-0.26-1.38-1.13
High estimate-0.23-0.22-1.12-0.34
Year ago EPS-0.58-0.52-2.19-1.28
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate1.17M1.75M6.41M6.79M
Low estimate900k900k4.8M3.12M
High estimate1.88M2.95M9.94M12.55M
Year ago sales6.93M4.87M20.97M6.41M
Sales growth (year/est)-83.10%-64.00%-69.40%5.90%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.54-0.52-0.41-0.4
Actual EPS-0.58-0.52-0.59-0.56
Difference-0.040-0.18-0.16
Surprise %-7.40%0.00%-43.90%-40.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.27-0.24-1.28-0.81
7 days ago-0.27-0.22-1.25-0.88
30 days ago-0.27-0.22-1.25-0.88
60 days ago-0.25-0.22-1.09-1.02
90 days ago-0.25-0.25-1.15-1.11
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 days111N/A
Growth estimatesCARAIndustrySector(s)S&P 500
Current qtr.53.40%N/AN/AN/A
Next qtr.53.80%N/AN/AN/A
Current year41.60%N/AN/AN/A
Next year36.70%N/AN/AN/A
Next 5 years (per annum)110.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A